Neurodegenerative diseases pose a substantial socioeconomic burden on society.
Unfortunately, the aging world population and lack of effective cures foreshadow a negative …

Following Alzheimer's, Parkinson's disease (PD) is the second-most common
neurodegenerative disorder, sharing an unclear pathophysiology, a multifactorial profile …

Turmeric (Curcuma longa L.) is a popular natural drug, traditionally used for the treatment of
a wide range of diseases. Its root, as its most popular part used for medicinal purposes …

The most critical problem in the treatment of neurodegenerative diseases is brain neuronal
protection, which can be overcome by clearing pathological substances and regulating the …

Protein aggregation within the central nervous system has been recognized as a defining
feature of neurodegenerative diseases since the early 20th century. Since that time, there …

In human beings, Parkinson's disease (PD) is associated with the oligomerization and
amyloid formation of α-synuclein (α-Syn). The polyphenolic Asian food ingredient curcumin …

The failure of several Phase II/III clinical trials in Alzheimer's disease (AD) with drugs
targeting β‐amyloid accumulation in the brain fuelled an increasing interest in alternative …

Parkinson's disease (PD) pathology is characterized by the abnormal accumulation and
aggregation of the pre-synaptic protein α-synuclein in the dopaminergic neurons as Lewy …

Amyloid aggregation is a hallmark of several degenerative diseases affecting the brain or
peripheral tissues, whose intermediates (oligomers, protofibrils) and final mature fibrils …

The mechanism of interaction between imipenem and HSA was investigated by various
techniques like fluorescence, UV–vis absorbance, FRET, circular dichroism, urea …